Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1995 2
1996 2
1997 1
1999 1
2000 1
2001 3
2002 4
2003 3
2004 3
2005 7
2006 4
2007 4
2008 3
2010 1
2011 1
2012 2
2013 2
2014 2
2015 4
2016 4
2017 2
2018 1
2019 1
2020 2
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Dietary lutein modulates growth and survival genes in prostate cancer cells.
Rafi MM, Kanakasabai S, Gokarn SV, Krueger EG, Bright JJ. Rafi MM, et al. J Med Food. 2015 Feb;18(2):173-81. doi: 10.1089/jmf.2014.0003. Epub 2014 Aug 27. J Med Food. 2015. PMID: 25162762
In this study, we examined the effect of lutein on proliferation and survival-associated genes in prostate cancer (PC-3) cells. ...Flow cytometry analyses showed that lutein improved drug-induced cell cycle arrest and apoptosis in prostate cancer. ...
In this study, we examined the effect of lutein on proliferation and survival-associated genes in prostate cancer (PC-3) cells …
Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells.
Gunasekera RS, Sewgobind K, Desai S, Dunn L, Black HS, McKeehan WL, Patil B. Gunasekera RS, et al. Nutr Cancer. 2007;58(2):171-7. doi: 10.1080/01635580701328339. Nutr Cancer. 2007. PMID: 17640163
No such effect was observed when benign DTE cells were examined, demonstrating selective inhibition of extremely malignant AT3 prostate cancer cells relative to their benign parent. Lutein demonstrated a similar but slightly diminished response as lycopene. When cel …
No such effect was observed when benign DTE cells were examined, demonstrating selective inhibition of extremely malignant AT3 prostate
Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.
Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Graff RE, et al. Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19. Prostate. 2017. PMID: 28102015 Free PMC article. Clinical Trial.
METHODS: We conducted a nested case-control study, including 370 cases and 2,470 controls, to evaluate associations between pre-diagnostic alpha- and beta-carotene, alpha- and gamma-tocopherol, beta-cryptoxanthin, lutein, lycopene, retinol, and selenium with the risk of …
METHODS: We conducted a nested case-control study, including 370 cases and 2,470 controls, to evaluate associations between pre-diagnostic a …
Nutrition and cancer: a review of the evidence for an anti-cancer diet.
Donaldson MS. Donaldson MS. Nutr J. 2004 Oct 20;3:19. doi: 10.1186/1475-2891-3-19. Nutr J. 2004. PMID: 15496224 Free PMC article.
Protective elements in a cancer prevention diet include selenium, folic acid, vitamin B-12, vitamin D, chlorophyll, and antioxidants such as the carotenoids (alpha-carotene, beta-carotene, lycopene, lutein, cryptoxanthin). Ascorbic acid has limited benefits orally, but cou …
Protective elements in a cancer prevention diet include selenium, folic acid, vitamin B-12, vitamin D, chlorophyll, and antioxidants such as …
Associations of Subtype and Isomeric Plasma Carotenoids with Prostate Cancer Risk in Low-Income African and European Americans.
Lee SA, Cai Q, Franke AA, Steinwandel M, Wu J, Wen W, Zheng W, Blot WJ, Shu XO. Lee SA, et al. Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1846-1857. doi: 10.1158/1055-9965.EPI-20-1785. Epub 2021 Jul 16. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34272269 Free PMC article.
T3) = 2.13; 95% CI, 1.32-3.43; P (trend) = 0.002) and trans-lutein (OR(T1 vs. T3), 1.86; 95% CI, 1.20-2.88; P (trend) = 0.006) were positively associated with prostate cancer risk. ...CONCLUSIONS: The associations of carotenoids with risk of prostate cancer d …
T3) = 2.13; 95% CI, 1.32-3.43; P (trend) = 0.002) and trans-lutein (OR(T1 vs. T3), 1.86; 95% CI, 1.20-2.88; P (trend) = 0.006) were p …
Dietary Carotenoid Intakes and Prostate Cancer Risk: A Case-Control Study from Vietnam.
Van Hoang D, Pham NM, Lee AH, Tran DN, Binns CW. Van Hoang D, et al. Nutrients. 2018 Jan 11;10(1):70. doi: 10.3390/nu10010070. Nutrients. 2018. PMID: 29324670 Free PMC article.
The incidence of prostate cancer has increased in Vietnam, but there have been few studies of the risk factors associated with this change. ...No statistically significant associations were found for the intake of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutei
The incidence of prostate cancer has increased in Vietnam, but there have been few studies of the risk factors associated with this c …
Oxidative stress in prostate cancer patients: A systematic review of case control studies.
Oh B, Figtree G, Costa D, Eade T, Hruby G, Lim S, Elfiky A, Martine N, Rosenthal D, Clarke S, Back M. Oh B, et al. Prostate Int. 2016 Sep;4(3):71-87. doi: 10.1016/j.prnil.2016.05.002. Epub 2016 May 24. Prostate Int. 2016. PMID: 27689064 Free PMC article. Review.
BACKGROUND: Prostate cancer (PCa) is the most common cancer in men in Western countries. ...Results on markers of antioxidant capacity (superoxide dismutase, catalase, glutathione, glutathione reductase, glutathione peroxidase, uric acid, lutein, lycopene, beta caro …
BACKGROUND: Prostate cancer (PCa) is the most common cancer in men in Western countries. ...Results on markers of antioxidant capacit …
Diet and cancer.
Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Divisi D, et al. Acta Biomed. 2006 Aug;77(2):118-23. Acta Biomed. 2006. PMID: 17172193 Review.
Protective elements in a cancer-preventive diet include selenium, folic acid, vitamin B12, vitamin D, chlorophyll and antioxidants such as carotenoids (alpha-carotene, beta-carotene, lycopene, lutein, cryptoxanthin). Ascorbic acid has limited benefits if taken orally, but …
Protective elements in a cancer-preventive diet include selenium, folic acid, vitamin B12, vitamin D, chlorophyll and antioxidants such as c …
Risk assessment for the carotenoids lutein and lycopene.
Shao A, Hathcock JN. Shao A, et al. Regul Toxicol Pharmacol. 2006 Aug;45(3):289-98. doi: 10.1016/j.yrtph.2006.05.007. Epub 2006 Jun 30. Regul Toxicol Pharmacol. 2006. PMID: 16814439 Review.
Lutein and lycopene, two prevalent carotenoids in the human diet have become increasingly popular ingredients in dietary supplements. ...The OSL risk assessment method indicates that the evidence of safety is strong at intakes up to 20mg/d for lutein, and 75 mg/d fo
Lutein and lycopene, two prevalent carotenoids in the human diet have become increasingly popular ingredients in dietary supplements.
Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas.
Zhang J, Dhakal I, Stone A, Ning B, Greene G, Lang NP, Kadlubar FF. Zhang J, et al. Nutr Cancer. 2007;59(1):46-53. doi: 10.1080/01635580701385900. Nutr Cancer. 2007. PMID: 17927501
After adjustment for confounders, plasma levels of lycopene, lutein/zeaxanthin, and beta-cryptoxanthin were inversely associated with prostate cancer risk. ...This study added to the emerging evidence that high circulating levels of lycopene, lutein/zeaxanthi …
After adjustment for confounders, plasma levels of lycopene, lutein/zeaxanthin, and beta-cryptoxanthin were inversely associated with …
58 results